tradingkey.logo
tradingkey.logo
Search

Artivion Inc

AORT
Add to Watchlist
25.080USD
+0.430+1.74%
Close 09-11 16:00ET
1.22BMarket Cap
97.70P/E TTM
After-hours 19:00 (ET)25.080USD-0.020-0.08%

More Details of Artivion Inc Company

Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons’ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.

Artivion Inc Profile

Ticker SymbolAORT
Company nameArtivion Inc
IPO dateFeb 12, 1993
CEOMackin (James Patrick)
Number of employees1600
Security typeOrdinary Share
Fiscal year-endFeb 12
Address1655 Roberts Boulevard N W
CityKENNESAW
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code30144
Phone17704193355
Websitehttps://artivion.com/
Ticker SymbolAORT
IPO dateFeb 12, 1993
CEOMackin (James Patrick)

Company Executives of Artivion Inc

Name
Name/Position
Position
Shareholding
Change
Mr. John E. Davis
Mr. John E. Davis
Chief Commercial Officer
Chief Commercial Officer
203.01K
+7.32%
Mr. John E. Davis
Mr. John E. Davis
Chief Commercial Officer
Chief Commercial Officer
203.01K
+7.32%
Mr. John E. Davis
Mr. John E. Davis
Chief Commercial Officer
Chief Commercial Officer
203.01K
+7.32%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer
166.83K
-0.43%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer
166.83K
-0.43%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer
166.83K
-0.43%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
157.64K
+4.81%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
157.64K
+4.81%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
157.64K
+4.81%
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
157.47K
+4.81%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. John E. Davis
Mr. John E. Davis
Chief Commercial Officer
Chief Commercial Officer
203.01K
+7.32%
Mr. John E. Davis
Mr. John E. Davis
Chief Commercial Officer
Chief Commercial Officer
203.01K
+7.32%
Mr. John E. Davis
Mr. John E. Davis
Chief Commercial Officer
Chief Commercial Officer
203.01K
+7.32%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer
166.83K
-0.43%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer
166.83K
-0.43%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer
166.83K
-0.43%

FAQs

Who are the top five shareholders of Artivion Inc?

The top five shareholders of Artivion Inc are: Mr. John E. Davis

How many institutions hold shares of Artivion Inc (AORT)?

As of 2026Q1, 449 institutions hold shares of Artivion Inc, with a combined market value of approximately 45.29M, accounting for 93.40% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 501666.00.

What is the biggest source of revenue for Artivion Inc?

In 2026Q1, the Aortic stent grafts business generated the highest revenue for Artivion Inc, amounting to 46.41M and accounting for 36.91% of total revenue.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.